DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Tezosentan
Tezosentan
Endothelin System and Therapeutic Application of Endothelin Receptor
(12) United States Patent )-X- NZ
Modifications to the Harmonized Tariff Schedule of the United States To
I Regulations
CPU0213, a Novel Endothelin Type a and Type B Receptor Antagonist, Protects Against Myocardial Ischemia/Reperfusion Injury in Rats
09-002 Phrma Heartdis09
(12) United States Patent (10) Patent No.: US 8,158,152 B2 Palepu (45) Date of Patent: Apr
REVIEW Pharmacotherapy for Meconium Aspiration
WO 2014/151206 Al 25 September 2014 (25.09.2014) P O P C T
Phase I Dose-Escalation Study of the Safety and Pharmacokinetics of Atrasentan: an Endothelin Receptor Antagonist for Refractory Prostate Cancer1
Stembook 2018.Pdf
Rescue of Pulmonary Hypertension with an Oral Sulfonamide Antibiotic Sulfisoxazole by Endothelin Receptor Antagonistic Actions
Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders
US 2014/0057832 A1 Conrad Et Al
Tezosentan Decreases Pulmonary Artery Pressure and Improves Survival Rate in an Animal Model of Meconium Aspiration
Distinct ETA Receptor Binding Mode of Macitentan As Determined by Site Directed Mutagenesis
Late-Breaking Abstracts
OTHER ARTICLES NOTED (04 October 2007 to 23 January 2008)
Top View
WO 2018/005695 Al O
Supporting Information
Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
Clinical Trials with Endothelin Receptor Antagonists: What Went Wrong and Where Can We Improve?☆
Lääkeaineiden Yleisnimet (INN-Nimet) 31.12.2019
Tezosentan, an Endothelin Receptor Antagonist, Limits Liver Injury in Endotoxin Challenged Cirrhotic Rats Gut: First Published As on 11 November 2004
Clinical Trials with Endothelin Receptor Antagonists: What Went Wrong and Where Can We Improve?☆
O-Ribose Methyltransferase Nsp16 of SARS-Cov-2
Late Breaking Abstracts
Trend Analysis of a Database of Intravenous Pharmacokinetic Parameters in Humans for 1352 Drug Compounds
Drug Monographs
Endothelin Yoshifumi Kawanabe University of Toledo
Gold Standard Drug Monographs
Clinicalkey Drug Monographs
Short-Term Endothelin Receptor Blockade with Tezosentan Has Both Immediate and Long-Term Beneficial Effects in Rats with Myocard
Cardiovascular Disease
Q:\Users\Brendac\Pharmaceutical Zeroforzero Initiative FINAL Edited